Optimizing Liposomal Drug Delivery for Enhanced Efficacy in Skin Cancer Treatment: A Comprehensive Experimental Investigation

  • Jasmine Dhiman Global Group of Institution, Kahanpur Khuhi, Anandpur Sahib, Rupnagar 140117, India
  • Priya Sharma Global Group of Institution, Kahanpur Khuhi, Anandpur Sahib, Rupnagar 140117, India

Abstract

Skin cancer is a prevalent global health issue, necessitating ongoing research into innovative treatment approaches. This study focuses on assessing the effectiveness of a liposomal formulation to enhance skin cancer treatment and demonstrates its technological viability. A comprehensive literature review establishes the context by examining current skin cancer treatments and the role of liposomal formulations in dermatological therapies. The research objectives are clearly outlined, detailing the liposomal formulation's characteristics and experimental methodologies. Results from the study, including comparisons with existing treatments and statistical analyses, are presented, offering insights into the formulation's potential for advancing skin cancer therapy. The discussion section interprets the findings, addresses limitations, and underscores the transformative impact of liposomal formulations in skin cancer treatment. The conclusion succinctly summarizes key findings, emphasizing the study's significance. Furthermore, the future directions section outlines potential research avenues and improvements to the liposomal formulation. This research contributes to the evolving landscape of skin cancer treatment, highlighting the promising role of liposomal formulations in enhancing therapeutic outcomes. By bridging the gap between scientific innovation and clinical application, this study provides valuable insights into the potential of liposomal formulations to revolutionize skin cancer treatment, ultimately contributing to improved patient outcomes and a more effective approach to combating this widespread and pressing health concern.


Keywords: Liposomal formulation, Skin cancer treatment, Technological viability, Comparative analysis, Transformative impact, Methodologies

Keywords: Liposomal formulation, Skin cancer treatment, Technological viability, Comparative analysis, Transformative impact, Methodologies

Downloads

Download data is not yet available.

Author Biographies

Jasmine Dhiman, Global Group of Institution, Kahanpur Khuhi, Anandpur Sahib, Rupnagar 140117, India

Global Group of Institution, Kahanpur Khuhi, Anandpur Sahib, Rupnagar 140117, India

Priya Sharma, Global Group of Institution, Kahanpur Khuhi, Anandpur Sahib, Rupnagar 140117, India

Global Group of Institution, Kahanpur Khuhi, Anandpur Sahib, Rupnagar 140117, India

References

1.Garcovich S, Colloca G, Sollena P, Andrea B, Balducci L, Cho WC, et al. Skin cancer epidemics in the elderly as an emerging issue in geriatric oncology. Aging and disease. 2017;8(5):643. https://doi.org/10.14336/AD.2017.0503 PMid:28966807 PMCid:PMC5614327
2.James J. The health of populations: Beyond medicine: Academic Press; 2015.
3.Seth D, Cheldize K, Brown D, Freeman EE. Global burden of skin disease: inequities and innovations. Current dermatology reports. 2017;6:204-10. https://doi.org/10.1007/s13671-017-0192-7 PMid:29226027 PMCid:PMC5718374
4.Leonardi GC, Falzone L, Salemi R, Zanghì A, Spandidos DA, Mccubrey JA, et al. Cutaneous melanoma: From pathogenesis to therapy. International journal of oncology. 2018;52(4):1071-80. https://doi.org/10.3892/ijo.2018.4287 PMid:29532857 PMCid:PMC5843392
5.Saiding Q, Zhang Z, Chen S, Xiao F, Chen Y, Li Y, et al. Nano-bio interactions in mRNA nanomedicine: Challenges and opportunities for targeted mRNA delivery. Advanced Drug Delivery Reviews. 2023;203:115116. https://doi.org/10.1016/j.addr.2023.115116 PMid:37871748
6.Simoes MF, Sousa JS, Pais AC. Skin cancer and new treatment perspectives: A review. Cancer letters. 2015;357(1):8-42. https://doi.org/10.1016/j.canlet.2014.11.001 PMid:25444899
7.Li W, Zheng N, Zhou Q, Alqahtani MS, Elkamchouchi DH, Zhao H, et al. A state-of-the-art analysis of pharmacological delivery and artificial intelligence techniques for inner ear disease treatment. Environmental Research. 2023;236:116457. https://doi.org/10.1016/j.envres.2023.116457 PMid:37459944
8.Immordino ML, Dosio F, Cattel L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. International journal of nanomedicine. 2006;1(3):297.
9.Pratt-Chapman M, Bhadelia A. Patient-Reported outcomes in health economic decision-making: a changing landscape in oncology. Regulatory and Economic Aspects in Oncology. 2019:67-83. https://doi.org/10.1007/978-3-030-01207-6_6 PMid:30543008
10.Anastasia Balafouti Ã, Pippa N, Pispas S. Stimulus-responsive liposomes as smart nanocarriers for drug delivery applications. Novel Platforms for Drug Delivery Applications. 2022:177.https://doi.org/10.1016/B978-0-323-91376-8.00013-6
11.Keservani RK, Kesharwani RK, Sharma AK. Advances in Novel Formulations for Drug Delivery: John Wiley & Sons; 2023. https://doi.org/10.1002/9781394167708
12.Gunaratnam Y, Oliviere D. Narrative and stories in health care: illness, dying and bereavement: OUP Oxford; 2009. https://doi.org/10.1093/acprof:oso/9780199546695.001.0001
13.Ninduwezuor-Ehiobu N, Tula OA, Daraojimba C, Ofonagoro KA, Ogunjobi OA, Gidiagba JO, et al. EXPLORING INNOVATIVE MATERIAL INTEGRATION IN MODERN MANUFACTURING FOR ADVANCING US COMPETITIVENESS IN SUSTAINABLE GLOBAL ECONOMY. Engineering Science & Technology Journal. 2023;4(3):140-68. https://doi.org/10.51594/estj.v4i3.558
14.Zeng Q, Chen C, Chen D, Zhang G, Wang X. Non-Surgical Therapeutic Strategies for Non-Melanoma Skin Cancers. Current Treatment Options in Oncology. 2023:1-16. https://doi.org/10.1007/s11864-023-01154-4 PMid:38095778
15.Darragh LB. Improving Response to Immunotherapy in Head and Neck Squamous Cell Carcinoma by Reducing Nodal Irradiation: University of Colorado Denver, Anschutz Medical Campus; 2023.
16.Horlock N. The cell biology of basal cell carcinoma: Relationship to histology and clinical outcome: University of London, University College London (United Kingdom); 1998.
17.Mishra DK, Shandilya R, Mishra PK. Lipid based nanocarriers: a translational perspective. Nanomedicine: Nanotechnology, Biology and Medicine. 2018;14(7):2023-50. https://doi.org/10.1016/j.nano.2018.05.021 PMid:29944981
18.Wang Y, Zhang P, Wei Y, Shen K, Xiao L, Miron RJ, et al. Cell‐membrane‐display nanotechnology. Advanced Healthcare Materials. 2021;10(1):2001014. https://doi.org/10.1002/adhm.202001014 PMid:33000917
19.Venkatakrishnan K, Friberg LE, Ouellet D, Mettetal J, Stein A, Trocóniz I, et al. Optimizing oncology therapeutics through quantitative translational and clinical pharmacology: challenges and opportunities. Clinical Pharmacology & Therapeutics. 2015;97(1):37-54. https://doi.org/10.1002/cpt.7 PMid:25670382
20.Wen H, Jung H, Li X. Drug delivery approaches in addressing clinical pharmacology-related issues: opportunities and challenges. The AAPS journal. 2015;17:1327-40. https://doi.org/10.1208/s12248-015-9814-9 PMid:26276218 PMCid:PMC4627459
21.Nisini R, Poerio N, Mariotti S, De Santis F, Fraziano M. The multirole of liposomes in therapy and prevention of infectious diseases. Frontiers in Immunology. 2018;9:155. https://doi.org/10.3389/fimmu.2018.00155 PMid:29459867 PMCid:PMC5807682
22.Çağdaş M, Sezer AD, Bucak S. Liposomes as potential drug carrier systems for drug delivery. Application of nanotechnology in drug delivery. 2014;1:1-50. https://doi.org/10.5772/58459
23.Kanwar JR, Kamalapuram SK, Kanwar RK. Survivin signaling in clinical oncology: a multifaceted dragon. Medicinal research reviews. 2013;33(4):765-89. https://doi.org/10.1002/med.21264 PMid:22688671
24.Olusanya TO, Haj Ahmad RR, Ibegbu DM, Smith JR, Elkordy AA. Liposomal drug delivery systems and anticancer drugs. Molecules. 2018;23(4):907. https://doi.org/10.3390/molecules23040907 PMid:29662019 PMCid:PMC6017847
25. Parajapati SK, Maurya SD, Das MK, Tilak VK, Verma KK, Dhakar RC, Potential application of dendrimers in drug delivery: A concise review and update, Journal of Drug Delivery and Therapeutics, 2016;6(2):71-88 https://doi.org/10.22270/jddt.v6i2.1195
26.Belfiore L, Saunders DN, Ranson M, Thurecht KJ, Storm G, Vine KL. Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities. Journal of controlled release. 2018;277:1-13. https://doi.org/10.1016/j.jconrel.2018.02.040 PMid:29501721
27.Rommasi F, Esfandiari N. Liposomal nanomedicine: applications for drug delivery in cancer therapy. Nanoscale Research Letters. 2021;16(1):95. https://doi.org/10.1186/s11671-021-03553-8 PMid:34032937 PMCid:PMC8149564
28.Ahmed KS, Hussein SA, Ali AH, Korma SA, Lipeng Q, Jinghua C. Liposome: Composition, characterisation, preparation, and recent innovation in clinical applications. Journal of drug targeting. 2019;27(7):742-61. https://doi.org/10.1080/1061186X.2018.1527337 PMid:30239255
29.Chattopadhyay S, Modesto-Lopez LB, Venkataraman C, Biswas P. Size distribution and morphology of liposome aerosols generated by two methodologies. Aerosol Science and Technology. 2010;44(11):972-82. https://doi.org/10.1080/02786826.2010.498797
30.Lestini BJ, Sagnella SM, Xu Z, Shive MS, Richter NJ, Jayaseharan J, et al. Surface modification of liposomes for selective cell targeting in cardiovascular drug delivery. Journal of Controlled Release. 2002;78(1-3):235-47. https://doi.org/10.1016/S0168-3659(01)00505-3 PMid:11772464
31.Laouini A, Jaafar-Maalej C, Limayem-Blouza I, Sfar S, Charcosset C, Fessi H. Preparation, characterization and applications of liposomes: state of the art. Journal of colloid Science and Biotechnology. 2012;1(2):147-68. https://doi.org/10.1166/jcsb.2012.1020
32.Cunha C, Daniel-da-Silva AL, Oliveira H. Drug Delivery Systems and Flavonoids: Current Knowledge in Melanoma Treatment and Future Perspectives. Micromachines. 2022;13(11):1838. https://doi.org/10.3390/mi13111838 PMid:36363859 PMCid:PMC9693869
33.Guimarães D, Cavaco-Paulo A, Nogueira E. Design of liposomes as drug delivery system for therapeutic applications. International journal of pharmaceutics. 2021;601:120571. https://doi.org/10.1016/j.ijpharm.2021.120571 PMid:33812967
34.Jain A, Hurkat P, Jain SK. Development of liposomes using formulation by design: Basics to recent advances. Chemistry and physics of lipids. 2019;224:104764. https://doi.org/10.1016/j.chemphyslip.2019.03.017 PMid:30951713
35.Fidan Y, Mucaj S, Timur SS, Gürsoy RN. Recent advances in liposome-based targeted cancer therapy. Journal of Liposome Research. 2023:1-19. https://doi.org/10.1080/08982104.2023.2268710 PMid:37814217
36.Bibi S, Kaur R, Henriksen-Lacey M, McNeil SE, Wilkhu J, Lattmann E, et al. Microscopy imaging of liposomes: from coverslips to environmental SEM. International journal of pharmaceutics. 2011;417(1-2):138-50. https://doi.org/10.1016/j.ijpharm.2010.12.021 Mid:21182914
37.Smith MC, Crist RM, Clogston JD, McNeil SE. Zeta potential: a case study of cationic, anionic, and neutral liposomes. Analytical and bioanalytical chemistry. 2017;409:5779-87. https://doi.org/10.1007/s00216-017-0527-z PMid:28762066
38.Solomon D, Gupta N, Mulla NS, Shukla S, Guerrero YA, Gupta V. Role of in vitro release methods in liposomal formulation development: challenges and regulatory perspective. The AAPS journal. 2017;19:1669-81. https://doi.org/10.1208/s12248-017-0142-0 PMid:28924630
39.Trinh HT, Mohanan S, Radhakrishnan D, Tiburcius S, Yang J-H, Verrills NM, et al. Silica-based nanomaterials as drug delivery tools for skin cancer (melanoma) treatment. Emergent Materials. 2021;4(5):1067-92. https://doi.org/10.1007/s42247-021-00236-z
40.Raju R, Abuwatfa WH, Pitt WG, Husseini GA. Liposomes for the treatment of brain cancer-A review. Pharmaceuticals. 2023;16(8):1056. https://doi.org/10.3390/ph16081056 PMid:37630971 PMCid:PMC10458450
41.Kaur H, Kesharwani P. Advanced nanomedicine approaches applied for treatment of skin carcinoma. Journal of Controlled Release. 2021;337:589-611. https://doi.org/10.1016/j.jconrel.2021.08.003 PMid:34364919
Crossmark
Statistics
80 Views | 9 Downloads
How to Cite
1.
Dhiman J, Sharma P. Optimizing Liposomal Drug Delivery for Enhanced Efficacy in Skin Cancer Treatment: A Comprehensive Experimental Investigation. JDDT [Internet]. 15Jun.2024 [cited 17Jul.2024];14(6):87-. Available from: https://jddtonline.info/index.php/jddt/article/view/6566